Last reviewed · How we verify
NCT03931226: PEDIATHERM
Impact of Spa Treatments on the Consumption of Care in Children
trial testing Drug consumption in Respiratory Disease in 8,372 participants. Completed in 31 December 2022.
31 December 2022
Quick facts
| Lead sponsor | University Hospital, Toulouse |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 8,372 |
| Start date | 1 June 2018 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- Drug consumption — full drug profile →
Conditions studied
- Respiratory Disease — all drugs for Respiratory Disease →
- Otorhinolaryngologic Diseases — all drugs for Otorhinolaryngologic Diseases →
- Dermatologic Disease — all drugs for Dermatologic Disease →
Sponsor
University Hospital, Toulouse
Who can join
Adults 1 to 15, any sex, with Respiratory Disease or Otorhinolaryngologic Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Children represent 1.2% of the spa population in France. Spa treatments, including climatic stays, are mainly prescribed for children in the context of respiratory, otorhinolaryngology and dermatological conditions. The benefits after spa treatments are the improvement of the symptoms of the pathology, the quality of life and in particular the reduction of drug exposures. Few authors have recently investigated the impact of spa treatments on the health of children and society, while care has changed significantly in recent years. Moreover, no real-life study of a large sample of children seems to have been conducted in this area. The present study plan to conduct a pharmacoepidemiology study on medico-administrative databases of the "observational study" type, in real life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03931226
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Respiratory Disease
Currently open trials in the same condition.
- NCT06716502 — A New Portable Device for Non-invasive Ventilatory Support · NA · recruiting
- NCT06455033 — Manual Diaphragm Release on Stepping Reaction Time in Chronic Obstructive Pulmonary Disease · NA · active not recruiting
- NCT06796894 — Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics · recruiting
- NCT06503913 — Cognitive Muscular Therapy for Patients With Long-COVID and Breathing Pattern Disorder · NA · active not recruiting
- NCT06569940 — Sleepiz One+ vs. Capnography and Electrocardiography · NA · recruiting
Other University Hospital, Toulouse trials
Trials by the same sponsor.
- NCT07497750 — Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver D · NA · not yet recruiting
- NCT07507240 — The Benefits of a Care Pathway Combining Remote Monitoring and Support From a Nurse After a Change in Anti-epileptic Tre · NA · not yet recruiting
- NCT07524088 — Contamination of Young Children Hair During Acute Cannabis Intoxication · NA · not yet recruiting
- NCT07470580 — Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension · NA · not yet recruiting
- NCT07423988 — Evaluation of Changes in Sleep Efficiency Among PIC DU MIDI Staff Between Nights Spent at Home and Nights Spent in the W · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03931226 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Toulouse
- Last refreshed: 13 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03931226.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing